BGAM
DGX icon

Boussard & Gavaudan Asset Management’s Quest Diagnostics DGX Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,104
Closed -$241K – 20
2014
Q2 		$241K Sell
4,104
-129
-3% -$7.55K 0.12% 80
2014
Q1 		$244K Buy
+4,233
New +$227K 0.15% 47

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Boussard & Gavaudan Asset Management's DGX Position: Q3 2014 in Review

Boussard & Gavaudan Asset Management sold out of Quest Diagnostics (DGX) in Q3 2014, closing a stake of 4,104 shares — an estimated $241K sold.

Boussard & Gavaudan Asset Management first reported a position in DGX in Q1 2014 and held it in 2 quarters. The position peaked at $244K in Q1 2014. 485 funds tracked by Wall St. Rank hold DGX as of Q3 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Quest Diagnostics position as of Q3 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 4,104 Quest Diagnostics shares in Q3 2014, an estimated $241K.
  • Boussard & Gavaudan Asset Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 2 quarters.
  • Boussard & Gavaudan Asset Management's Quest Diagnostics position peaked at $244K in Q1 2014.
  • 485 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q3 2014.